Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-27

Clinical Trial Update: Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 study evaluating Tozuleristide with Blaze's Canvas Imaging System in pediatric central nervous system tumors undergoing surgery, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tozuleristide (tozuleristide)

Snippet

Sponsor: Blaze Bioscience Inc. | Conditions: Pediatric Central Nervous System Tumor | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-06-27